To make things easier, leave this box checked On shared devices, we recommend that you disconnect from Euroquity when you are done
Email

You will receive an email to define a new password

Location

Select your country

and your language

Hi ,

Welcome to your personnel profile page! Fill in your information in order to become more visible to organizations that interest you.

% completed

%

medal 1
This profile is validated by 1 label.

Company

LenioBio GmbH

LenioBio GmbH_logo
18
EQ SCORE

The EQ Score shows the company's activity and appeal on the platform: profile completeness, news, likes, follows, membership in one or more labels or communities, number of members in its network, etc.

At LenioBio we are committed to the advancement of trans-formative technology platforms for the discovery, development and synthesis of ‘difficult-to-produce’ proteins unconstrained by the limitations of the cell.

Düsseldorf, Stadt, Nordrhein-Westfalen, Germany

Send a message

English

LenioBio GmbH

English

At LenioBio we are committed to the advancement of transformative technology platforms for the discovery, development and synthesis of ‘difficult-to-produce’ proteins unconstrained by the limitations of the cell.

Our aim is to deliver solutions which will yield greater efficiencies along the whole protein development chain, enabling the relevant sectors to speed up the introduction of proteins that are more effective and less expensive.

Our first product, the cell-free...

See more

At LenioBio we are committed to the advancement of transformative technology platforms for the discovery, development and synthesis of ‘difficult-to-produce’ proteins unconstrained by the limitations of the cell.

Our aim is to deliver solutions which will yield greater efficiencies along the whole protein development chain, enabling the relevant sectors to speed up the introduction of proteins that are more effective and less expensive.

Our first product, the cell-free protein expression kit ALiCE® was launched in October 2018; This eukaryotic kit offers our customers the highest protein yields in a single step than any other cell free expression system currently available. The ALiCE® platform has years of validation as one of the cornerstone protein expression technologies in leading biotech companies.

Team member(s)

Your request has been sent
Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

European Innovation Council - Accelerator beneficiaries
This label is a guarantee for investors to discover selected companies benefiting from Business acceleration services provided by the European Commission.
167 Entities